Use of boosted protease inhibitors reduces Kaposi sarcoma incidence among male veterans with HIV infection.
about
HAART and lungs: do HIV protease inhibitors impact cancer risk?Cancer prevention in HIV-infected populations.Changing Incidence and Risk Factors for Kaposi Sarcoma by Time Since Starting Antiretroviral Therapy: Collaborative Analysis of 21 European Cohort Studies.Diagnosis and Treatment of Kaposi Sarcoma.[TB/HIV co-infection associated with Kaposi's sarcoma under opioid substitution treatment using methadone: about a case].
P2860
Use of boosted protease inhibitors reduces Kaposi sarcoma incidence among male veterans with HIV infection.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Use of boosted protease inhibi ...... e veterans with HIV infection.
@ast
Use of boosted protease inhibi ...... e veterans with HIV infection.
@en
type
label
Use of boosted protease inhibi ...... e veterans with HIV infection.
@ast
Use of boosted protease inhibi ...... e veterans with HIV infection.
@en
prefLabel
Use of boosted protease inhibi ...... e veterans with HIV infection.
@ast
Use of boosted protease inhibi ...... e veterans with HIV infection.
@en
P2093
P2860
P356
P1476
Use of boosted protease inhibi ...... e veterans with HIV infection.
@en
P2093
Elizabeth Y Chiao
Insia Suteria
Jennifer R Kramer
Marc A Kowalkowski
Peter R Richardson
P2860
P304
P356
10.1093/CID/CIV012
P407
P577
2015-01-13T00:00:00Z